KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Shares Issued: 2013-2025

Historic Shares Issued for Travere Therapeutics (TVTX) over the last 9 years, with Sep 2025 value amounting to $4.1 million.

  • Travere Therapeutics' Shares Issued was N/A to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year change of. This contributed to the annual value of $134.7 million for FY2024, which is 29.53% down from last year.
  • Latest data reveals that Travere Therapeutics reported Shares Issued of $4.1 million as of Q3 2025, which was up 783.37% from $463,000 recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Shares Issued ranged from a high of $182.6 million in Q4 2021 and a low of $122,000 during Q1 2022.
  • Moreover, its 3-year median value for Shares Issued was $4.2 million (2025), whereas its average is $28.0 million.
  • As far as peak fluctuations go, Travere Therapeutics' Shares Issued tumbled by 99.87% in 2022, and later skyrocketed by 20,088.52% in 2023.
  • Travere Therapeutics' Shares Issued (Quarterly) stood at $182.6 million in 2021, then slumped by 99.87% to $231,000 in 2022, then spiked by 20,088.52% to $24.6 million in 2023, then reached $133.4 million in 2024, then crashed by 64.58% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $463,000 for Q2 2025, and $4.2 million during Q1 2025.